Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker-guided Implementation of Angiotensin-II (AT-II) to Reduce the Occurrence of Kidney Damage After Cardiac Surgery

NCT05199493 is registered in ClinicalTrials.gov with Universität Münster as lead sponsor.

NCT NCT05199493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05199493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker-guided Implementation of Angiotensin-II (AT-II) to Reduce the Occurrence of Kidney Damage After Cardiac Surgery
Lead sponsor
Universität Münster
Phase
Phase 3
Overall status
Completed
Start date
December 27, 2021
Completion date
March 19, 2023
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery, hyperreninemia, vasoplegia